You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


NRG Therapeutics gains further funding from Parkinson’s UK

Cambridge-based biotech company NRG Therapeutics has received further funding of £490k from Parkinson’s UK, bringing the total amount invested by the charity to £2.5m.